Dana-Farber Cancer Institute
hideDana-Farber Cancer Institute is part of a Comprehensive Cancer Center designated by the National Cancer Institute. It is a major affiliate of Harvard Medical School and is located in the Longwood Medical Area in Boston, Massachusetts.
The origins of Dana-Farber date back to 1947 when Sidney Farber, MD, founded Children's Cancer Research Foundation. In 1974, it became known as the Sidney Farber Cancer Institute in honor of its founder. The support of the Charles A. Dana Foundation was acknowledged by incorporating Dana's name in 1983.
Dana-Farber employs about 3,150 people. There are more than 185,000 adult and pediatric patient visits a year, and it is involved in some 200 clinical trials. It is internationally known for its research and clinical excellence. Dana-Farber is a member of the Multiple Myeloma Research Consortium.
In addition to being a principal teaching affiliate of Harvard Medical School, Dana-Farber is also a federally designated Center for AIDS Research, and a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), a federally designated comprehensive cancer center. Providing advanced training in cancer treatment and research for an international faculty, Dana-Farber conducts community-based programs in cancer prevention, detection, and control throughout New England, and maintains joint programs with other Boston institutions affiliated with Harvard Medical School and the Partners HealthCare System, including Brigham and Women's Hospital, Children's Hospital, and Massachusetts General Hospital.
Dana-Farber is supported by the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, and private foundations and individuals contributions. The Jimmy Fund is the principal charity of the Institute named for one of its child patients. The Boston Red Sox adopted the Jimmy Fund as its official charity in 1953 and continues to prominently sponsor the charity.
For more information about Dana-Farber Cancer Institute, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with dana farber cancer institute
Blood type study sheds light on biology of pancreatic cancer
Mar 11, 2009 |
5 / 5 (1) |
0
(PhysOrg.com) -- Offering a novel clue about the basic biology of pancreatic cancer, researchers at Dana-Farber Cancer Institute have confirmed a decades-old discovery of a link between blood type and the ...
Study: Doctor-patient conversations at end of life associated with lower medical expenses
Mar 09, 2009 |
not rated yet |
1
Few physicians are eager to discuss end-of-life care with their patients. Yet such conversations may result in better quality of life for patients and could lower national healthcare expenditures for cancer care alone by ...
Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses
Biology /
Feb 22, 2009 |
5 / 5 (7) |
1
Researchers at the Dana-Farber Cancer Institute, Burnham Institute for Medical Research and the Centers for Disease Control and Prevention have reported the identification of human monoclonal antibodies (mAb) that neutralize ...
Studies offer guide as protein interaction mapping comes of age
Jan 06, 2009 |
5 / 5 (1) |
0
During the past 20 years, researchers have identified thousands of cell protein interactions, with the ultimate goal of inventorying all that occur within cells of various organisms - a comprehensive catalogue known as the ...
Search results for dana farber cancer institute
Long-term testicular cancer survivors at high risk for neurological side effects
19 hours ago |
not rated yet |
0
Long-term survivors of testicular cancer who were treated with cisplatin-based chemotherapy had more severe side effects, including neurological side effects and Raynaud-like phenomena, than men who were not treated with ...
Estrogen receptor-alpha, breast cancer patients and tamoxifen response
21 hours ago |
not rated yet |
0
Researchers have found evidence of a statistically significant survival benefit from adjuvant tamoxifen among patients whose estrogen receptor (ER)-positive tumors had high levels of phosphorylation of ER-alpha; at serine-118 ...
Implant-based cancer vaccine is first to eliminate tumors in mice
Nov 25, 2009 |
4.7 / 5 (22) |
6
(PhysOrg.com) -- A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal ...
Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis
Nov 25, 2009 |
not rated yet |
0
Two signaling pathways essential to normal human development - the Wnt/Wingless (Wnt) and epidermal growth factor receptor (EGFR) pathways - interact in ways that can promote tumor cell invasion and metastasis, researchers ...
Researchers discover biological basis of 'bacterial immune system'
Nov 25, 2009 |
4.7 / 5 (3) |
0
Bacteria don't have easy lives. In addition to mammalian immune systems that besiege the bugs, they have natural enemies called bacteriophages, viruses that kill half the bacteria on Earth every two days.
The tall and short of diseases
Nov 25, 2009 |
5 / 5 (2) |
0
(PhysOrg.com) -- Research shows that being taller means a fatter pay check and an increased risk of some cancers.
Scientists discover soy component may be key to fighting colon cancer
Nov 24, 2009 |
4 / 5 (1) |
0
A study conducted by Children's Hospital & Research Center Oakland scientists identifies a new class of therapeutic agents found naturally in soy that can prevent and possibly treat colon cancer, the third most deadly form ...
Discovery leads to effective treatment of painful skin condition
Nov 24, 2009 |
not rated yet |
0
Researchers at Huntsman Cancer Institute, in collaboration with a worldwide group of physicians and scientists, have discovered a remarkable treatment for a rare, yet debilitating, skin condition.
Tissue tension regulates tumor progression
Nov 23, 2009 |
not rated yet |
0
(PhysOrg.com) -- UCSF scientists have shown for the first time that the rigidity of a tissue can induce cancer. The research team identified an enzyme that is crucial for regulating tissue stiffness and demonstrated that ...
Arsenic biomethylation required for oxidative DNA damage
Nov 23, 2009 |
not rated yet |
0
Biomethylation of arsenic compounds appears to cause oxidative DNA damage and to increase their carcinogenicity, according to a new study published online November 23 in the Journal of the National Cancer Institute.
List of search results for dana farber cancer institute
